Welcome to our dedicated page for UNIVERSAL HEALTH SERVICES SEC filings (Ticker: UHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UNIVERSAL HEALTH SERVICES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UNIVERSAL HEALTH SERVICES's regulatory disclosures and financial reporting.
SUSSMAN ELLIOT J MD MBA reported acquisition or exercise transactions in this Form 4 filing.
Universal Health Services director Elliot J. Sussman received an equity grant in the form of restricted stock units of the company’s Class B Common Stock. He was awarded 1,217 restricted stock units, which increased his direct holdings to 7,330 shares after the transaction.
The grant was made at no cash cost to Sussman and was issued under the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan. All units are scheduled to vest on the earlier of May 20, 2027 or the next annual meeting of stockholders that occurs at least 50 weeks after the 2026 annual meeting date of May 20, 2026.
Universal Health Services director Eileen C. McDonnell received an equity grant under the company’s incentive plan. On May 20, 2026, she acquired 1,217 shares of Class B Common Stock at a stated price of $0.00 per share, increasing her direct holdings to 9,406 shares.
The footnote explains that the award consists of restricted stock units granted under the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan. All units vest on the earlier of May 20, 2027 or the next annual meeting of stockholders that is at least 50 weeks after the May 20, 2026 annual meeting date.
Singer Maria Ruderman reported acquisition or exercise transactions in this Form 4 filing.
Universal Health Services director Maria Ruderman Singer received a grant of 1,217 shares of Class B Common Stock as a stock award, with no cash paid per share. After this grant, she directly holds 9,792 Class B shares.
The award consists of restricted stock units granted under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan. All units will vest on the earlier of May 20, 2027 or the next annual stockholder meeting that occurs at least 50 weeks after the May 20, 2026 annual meeting.
Nimetz Warren J. reported acquisition or exercise transactions in this Form 4 filing.
UNIVERSAL HEALTH SERVICES INC director Warren J. Nimetz received an award of 1,217 shares of Class B Common Stock in the form of restricted stock units at no cash cost. The units were granted under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan.
All units vest on the earlier of May 20, 2027 or the next annual meeting of stockholders that occurs at least 50 weeks after the May 20, 2026 annual meeting date. Following this award, Nimetz directly holds 9,698 shares of Class B Common Stock.
Universal Health Services, Inc. announced that Matthew J. Peterson, Executive Vice President and President of Behavioral Health, has resigned effective June 19, 2026. He has been with the company since 2019 and plans to pursue a non-competitive external opportunity.
As of the effective date, all of his unvested stock options, restricted stock units and performance-based restricted stock units will terminate. After that date, he will receive only amounts already accrued and vested under company benefit plans and any payments required by law.
Chief Executive Officer and President Marc D. Miller will take on interim leadership of the Behavioral Health Care Division alongside its Senior Vice Presidents, while the company begins an immediate search for a permanent replacement.
Universal Health Services reported higher results for the quarter ended March 31, 2026. Net revenues rose to $4.50 billion from $4.10 billion a year earlier, with growth in both acute care and behavioral health segments, including its U.K. operations.
Net income attributable to UHS increased to $348.7 million, and diluted EPS grew to $5.65 from $4.80. Operating cash flow was strong at $401.6 million, funding $217.2 million of capital spending while total debt stood around $4.7 billion.
The company expanded its credit capacity by $900 million and agreed to acquire Talkspace, Inc. for about $835 million, to be financed under its credit facility. However, it faces significant legal exposure, including the Cumberland Litigation, and its Laurel Ridge Treatment Center has been terminated from Medicare and Medicaid, which is expected to drive operating losses during recertification efforts.
Universal Health Services Inc ownership disclosure: Vanguard Capital Management reports beneficial ownership of 3,922,926 shares of Common Stock, representing 7.28% of the class as reported with an ownership date of 03/31/2026. The filing states Vanguard exercises sole dispositive power over those shares and identifies 470,041 shares as subject to sole voting power. The filing is made on behalf of Vanguard and affiliated advisory units and is signed on 04/30/2026.
Universal Health Services, Inc. reported solid growth for the three months ended March 31, 2026. Net revenues rose 9.6% to $4.495 billion, while net income attributable to UHS increased to $348.7 million, or $5.65 per diluted share, up from $4.80 a year earlier. Adjusted net income was $346.5 million, or $5.62 per diluted share.
EBITDA net of noncontrolling interests was $651.7 million and Adjusted EBITDA net of NCI was $648.3 million. Same-facility acute care net revenues grew 8.2%, driven mainly by higher revenue per admission and patient day, while same-facility behavioral health revenues rose 7.3% on modest volume and pricing gains.
Operating cash flow improved to $401.6 million. The company amended its credit agreement in April 2026 to add an aggregate $900 million of borrowing capacity, including a new $400 million delayed draw term loan A tied to the planned acquisition of Talkspace, Inc., and continued capital returns with 675,000 Class B shares repurchased for about $127.3 million.
Universal Health Services, Inc. amended its long-standing senior secured credit agreement through an Eleventh Amendment, adding new revolving and term loan capacity and updating pricing. The company now has a new $200 million incremental revolving facility, a $300 million incremental tranche A term loan and a $400 million delayed draw term loan under its Senior Secured Credit Facility. The delayed draw term loan is intended to fund the previously announced acquisition of Talkspace, Inc. All incremental loans generally mature on September 26, 2029 and carry margins tied to the company’s Consolidated Net Leverage Ratio. The company also executed supplemental indentures adding new subsidiary guarantors to its various senior secured notes.